Silence Therapeutics PLC (NAS:SLN)
$ 22.94 0.61 (2.73%) Market Cap: 1.07 Bil Enterprise Value: 1.00 Bil PE Ratio: 0 PB Ratio: 40.25 GF Score: 49/100

Half Year 2020 Silence Therapeutics PLC Earnings Call Transcript

Sep 14, 2020 / 12:00PM GMT
Release Date Price: $19.5
Gem Gokmen Hopkins
Silence Therapeutics plc - Head of IR & Corporate Communications

Good morning, and good afternoon, and thank you for joining us for the Silence Therapeutics Half Year 2020 Results Call. Having recently joined Silence as Head of Investor Relations and Corporate Communications, I am delighted to introduce the call today from the company's New York office.

During the call, we will be walking through a slide presentation. If you haven't already received the slide deck, please make sure to visit the Events page of our corporate website at www.silencetherapeutics.com to download a copy or follow along on the webcast.

I'd like to remind you that during the course of today's call, management will make projections or other forward-looking statements regarding anticipated future events or the future financial performance of the company, including clinical development objectives, the therapeutic potential of our product candidates, our operational plans and strategies and projected cash runway.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot